Parmax Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE240T01014
  • NSEID:
  • BSEID: 540359
INR
30.65
-0.15 (-0.49%)
BSENSE

Apr 10

BSE+NSE Vol: 30

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002724,
    "name": "Parmax Pharma",
    "stock_name": "Parmax Pharma",
    "full_name": "Parmax Pharma Ltd",
    "name_url": "stocks-analysis/parmax-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "30.65",
    "chg": -0.15,
    "chgp": "-0.49%",
    "dir": -1,
    "prev_price": "30.80",
    "mcapval": "12.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540359,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE240T01014",
    "curr_date": "Apr 10",
    "curr_time": "",
    "bse_nse_vol": "30 ",
    "exc_status": "Active",
    "traded_date": "Apr 10, 2026",
    "traded_date_str": "2026 04 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/parmax-pharma-1002724-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Parmax Pharma Ltd Falls to 52-Week Low of Rs 22.6 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-stock-falls-to-52-week-low-of-rs226-3915864",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ParmaxPharmaLtd_priceRelatedfactors_3915864.png",
        "date": "2026-03-25 10:02:56",
        "description": ""
      },
      {
        "title": "Parmax Pharma Ltd Falls to 52-Week Low of Rs 24.5 Amidst Continued Weakness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-falls-to-52-week-low-of-rs-245-amidst-continued-weakness-3898506",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ParmaxPharmaLtd_priceRelatedfactors_3898506.png",
        "date": "2026-03-18 10:04:09",
        "description": "Parmax Pharma Ltd, a micro-cap entity in the Pharmaceuticals & Biotechnology sector, has declined sharply to a new 52-week low of Rs.24.5, marking a significant drop of 11.71% in today’s trading session. This fresh low underscores the stock’s ongoing underperformance relative to its sector and broader market indices."
      },
      {
        "title": "Parmax Pharma Ltd Falls to 52-Week Low of Rs 25 Amidst Weak Financials",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-falls-to-52-week-low-of-rs-25-amidst-weak-financials-3887189",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ParmaxPharmaLtd_priceRelatedfactors_3887189.png",
        "date": "2026-03-12 14:57:13",
        "description": "Parmax Pharma Ltd’s shares declined sharply to a new 52-week low of Rs.25 on 12 Mar 2026, marking a significant downturn amid ongoing financial headwinds and sector underperformance. The stock’s recent volatility and sustained downward trend reflect persistent challenges in the company’s financial metrics and market positioning."
      },
      {
        "title": "Parmax Pharma Q3 FY26: Mounting Losses Deepen as Revenue Plummets 72% YoY",
        "link": "https://www.marketsmojo.com/news/result-analysis/parmax-pharma-q3-fy26-mounting-losses-deepen-as-revenue-plummets-72-yoy-3842936",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ParmaxPharma_quaterlyResult_3842936.png",
        "date": "2026-02-16 22:05:05",
        "description": "Parmax Pharma Ltd., a micro-cap pharmaceutical company specialising in Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations (CMO), has reported deeply concerning financial results for Q3 FY26, with net losses widening to ₹0.73 crores whilst revenues collapsed 72.74% year-on-year to ₹2.53 crores. The company, trading at ₹32.00 with a market capitalisation of just ₹12.00 crores, has now recorded consecutive quarterly losses throughout FY26, raising serious questions about operational viability and management execution."
      },
      {
        "title": "When is the next results date for Parmax Pharma Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-parmax-pharma-ltd-3833797",
        "imagepath": "",
        "date": "2026-02-11 23:17:17",
        "description": "The next results date for Parmax Pharma Ltd is scheduled for 14 February 2026...."
      }
    ],
    "total": 116,
    "sid": "1002724",
    "stock_news_url": "https://www.marketsmojo.com/news/parmax-pharma-1002724"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "30-Mar-2026",
      "details": "Closure of trading window",
      "source": "BSE"
    },
    {
      "caption": "Appointment of Company Secretary and Compliance Officer",
      "datetime": "25-Mar-2026",
      "details": "Appointment of Ms. Bhakti Aghera as a Company Secretary",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "14-Feb-2026",
      "details": "Outcome of Board meeting for Financial Results",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Closure of Trading Window

30-Mar-2026 | Source : BSE

Closure of trading window

Appointment of Company Secretary and Compliance Officer

25-Mar-2026 | Source : BSE

Appointment of Ms. Bhakti Aghera as a Company Secretary

Board Meeting Outcome for Outcome Of Board Meeting

14-Feb-2026 | Source : BSE

Outcome of Board meeting for Financial Results

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available